| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |